UTERINE FIBROIDS: SYMPTOMS SEVERITY AND ITS IMPACT ON HEALTH-RELATED QUALITY OF LIFE AMONG WOMEN IN REPRODUCTIVE AGE GROUP IN NORTH KERALA

ABHILASH ANTONY V; HEERA SHENOY T; SHIVAKUMAR; CHELLAMMA VK; HIBA HASHIM

doi:10.22159/ajpcr.2022.v15i12.45970

Authors

ABHILASH ANTONY V Department of Obstetrics and Gynaecology, KMCT Medical College, Kozhikode, Kerala, India.
HEERA SHENOY T Department of Obstetrics and Gynaecology, KMCT Medical College, Kozhikode, Kerala, India. https://orcid.org/0000-0001-6197-0236
SHIVAKUMAR Department of Obstetrics and Gynaecology, KMCT Medical College, Kozhikode, Kerala, India.
CHELLAMMA VK Department of Obstetrics and Gynaecology, KMCT Medical College, Kozhikode, Kerala, India.
HIBA HASHIM Department of Obstetrics and Gynaecology, KMCT Medical College, Kozhikode, Kerala, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i12.45970

Keywords:

Uterine fibroids, Health-related quality of life, Reproductive age group

Abstract

Objectives: This study was conducted to determine the effect of uterine fibroids (UFs) and their symptoms severity and its impact on health-related quality of life (QoL) among women in reproductive age group reporting to a teaching medical institution in the state of Kerala.

Methods: The questionnaire QoL-life quality of patients with symptomatic UF was used to assess their QoL in 104 women attending outpatient department at KMCT Medical College from March 2021 to August 2021.

Results: Mean age was 45.86. About 34.62% of cases were in Obesity I category; followed by 13.46% of Obesity II. About 33.65% had UF with corporeal location; 44.23% in cervical and 22.12% had isthmic fibroids. About 32.69% showed presence of sub-serous; 42.67% had intramural and 24.04% had submucosal fibroid. HMB followed by abdominal pain and bladder dysfunction was the presenting features.

Conclusion: There was a strong negative correlation between symptoms and the UF QoL. This shows that with the increase in symptoms; the QoL was reduced in all the overall aspects. Hence, it was concluded that UF has a profound negative impact on the overall QoL in reproductive age women.

Downloads

Download data is not yet available.

References

Manyonda I, Belli AM, Lumsden MA, Moss J, McKinnon W, Middleton LJ, et al. Uterine-artery embolization or myomectomy for uterine fibroids. N Engl J Med 2020;383:440-51.

Drayer SM, Catherino WH. Prevalence, morbidity, and current medical management of uterine leiomyomas. Int J Gynecol Obstet 2015;131:117-22. doi: 10.1016/j.ijgo.2015.04.051

Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007;87:725-36.

Smailova LK, Iskakov SS, Tuletova AS, Shegenov GA, Kasenova DA. Assessing the quality of life of patients with symptomatic uterine fibroid. Syst Rev Pharm 2020;11:176-82.

Coyne KS, Margolis MK, Bradley LD, Guido R, Maxwell GL, Spies JB. Further validation of the uterine fibroid symptom and quality-of-life questionnaire. Value Health 2012;15:135-42. doi: 10.1016/j. jval.2011.07.007

Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: An ultrasound-screening study. Obstet Gynecol 2009;113:630-5.

Chen CR, Buck GM, Courey NG, Perez KM, Wactawski-Wende J. Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol 2001;153:20-6.

Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: Low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand 2000;79:202-7.

Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini P,Gavoni N, et al. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod 2004;19:2350-5.

Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol 2003;188:100-7.

Munusamy MM, Sheelaa WG, Lakshmi VP. Clinical presentation and prevalence of uterine fibroids: A 3-year study in 3-decade rural South Indian women. Int J Reprod Contracept Obstet Gynecol 2017;6:5596.

Mishra A, Mishra P, Kumar BN, Pandey T, Pandey M, Chaturvedi RK. Clinicopathological correlation of leiomyoma in a tertiary care centre: A retrospective study. J Med Sci Clin Res 2018;6:205-10.

Subramaniyam NK, Vanaja K, Chadeve A, Modapu D, Dumpala AJ, Gudise BR, et al. Prevalence of risk factors for uterine fibroids at tertiary care teaching hospital: A cross-sectional study. J Young Pharm 2020;12:86-9.

Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: A review. Environ Health Perspect 2003;111:1037-54.

Lobel MK, Somasundaram P, Morton CC. The genetic heterogeneity of uterine leiomyomata. Obstet Gynecol Clin North Am 2006;33:13-39.

Marshall LM, Spiegelman D, Manson JE, Goldman MB, Barbieri RL, Stampfer MJ, et al. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology 1998;9:511-7.

Padubidri VG, Daftary S. Shaw’s Textbook of Gynecology. 16th ed. India: Elsevier; 2014. p. 596.

Kulkarni MR, Dutta I, Dutta DK. Clinicopathological study of uterine leiomyomas: A multicentric study in rural population. J Obstet Gynecol India 2016;66:412-6.

Ibrar F, Raiz S, Dawood NS, Jabeen A. Frequency of fibroid uterus in multipara women in a tertiary care centre in Rawalpindi. J Ayub Med Coll Abbottabad 2010;22:155-7.

Khyade RL. A study of menstrual disturbance in cases of fibroid uterus. Int J Reprod Contracept Obstet Gynecol 2017;6:2494-7.

Shaheen S, Naheed T, Sadaf F, Rahim R. Menorrhagia due to fibroids and its management. JSOGP 2013;3:231-5.

Carranza-Mamane B, Havelock J, Hemmings R, Reproductive Endocrinology and Infertility Committee; Special Contributor. The management of uterine fibroids in women with otherwise unexplained infertility. J Obstet Gynaecol Can 2015;37:277-85.

Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: A systematic literature review from conception to delivery. Am J Obstet Gynecol 2008;198:357-66.

Knight J, Falcone T. Tissue extraction by morcellation: A clinical dilemma. J Minim Invasive Gynecol 2014;21:319-20.

Harding G, Coyne KS, Thompson CL, Spies JB. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Health Qual Life Outcomes 2008;6:99.

Carlson KJ, Miller BA, Fowler FJ Jr. The Maine women’s health study: I. Outcomes of hysterectomy. Obstet Gynecol 1994;83:556-65.

Rowe MK, Kanouse DE, Mittman BS, Bernstein SJ. Quality of life among women undergoing hysterectomies. Obstet Gynecol 1999;93:915-21.

Kjerulff KH, Langenberg PW, Rhodes JC, Harvey LA, Guzinski GM, Stolley PD. Effectiveness of hysterectomy. Obstet Gynecol 2000;95:319-26.

Scialli AR, Levi AJ. Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri. Fertil Steril 2000;74:540-6.

Spies JB, Warren EH, Mathias SD, Walsh SM, Roth AR, Pentecost MJ. Uterine fibroid embolization: Measurement of health-related quality of life before and after therapy. J Vasc Interv Radiol 1999;10:1293-303.

Pron G, Bennett J, Common A, Wall J, Asch M, Sniderman K, et al The Ontario uterine fibroid embolization trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 2003;79:120-7.

Kuppermann M, Varner RE, Summitt RL Jr., Learman LA, Ireland C, Vittinghoff E, et al. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: The medicine or surgery (Ms) randomized trial. JAMA 2004;291:1447-55.